Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,105 | -23,559 | -18,850 | -23,278 | -15,200 |
| Depreciation Amortization | 655 | 599 | 692 | 890 | 903 |
| Accounts receivable | -1,318 | -2,035 | -3,574 | 1,918 | -4,901 |
| Accounts payable and accrued liabilities | 355 | -63 | 25 | 67 | 1,154 |
| Other Working Capital | -1,591 | -1,245 | 5,543 | -5,217 | -1,843 |
| Other Operating Activity | 5,003 | 8,256 | 10,915 | 5,340 | 9,438 |
| Operating Cash Flow | $-8,001 | $-18,047 | $-5,249 | $-20,280 | $-10,449 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,114 | -722 | 6,734 | -1,010 | -723 |
| Investing Cash Flow | $-1,114 | $-722 | $6,734 | $-1,010 | $-723 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,632 | N/A | N/A |
| Debt Issued | N/A | N/A | 43,474 | N/A | N/A |
| Debt Repayment | -20 | -20 | -37 | -148 | -238 |
| Common Stock Issued | 488 | N/A | 86 | 365 | 67 |
| Other Financing Activity | 9,112 | 6,765 | -13,989 | 0 | 195 |
| Financing Cash Flow | $9,580 | $6,745 | $32,166 | $217 | $24 |
| Exchange Rate Effect | -466 | 113 | -191 | 395 | 103 |
| Beginning Cash Position | 31,741 | 43,652 | 10,192 | 30,870 | 41,915 |
| End Cash Position | 31,740 | 31,741 | 43,652 | 10,192 | 30,870 |
| Net Cash Flow | $-1 | $-11,911 | $33,460 | $-20,678 | $-11,045 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,001 | -18,047 | -5,249 | -20,280 | -10,449 |
| Capital Expenditure | -1,114 | -722 | -533 | -1,010 | -723 |
| Free Cash Flow | -9,115 | -18,769 | -5,782 | -21,290 | -11,172 |